2. Academic Validation
  3. Biallelic Truncating Mutations in ALPK3 Cause Severe Pediatric Cardiomyopathy

Biallelic Truncating Mutations in ALPK3 Cause Severe Pediatric Cardiomyopathy

  • J Am Coll Cardiol. 2016 Feb 9;67(5):515-25. doi: 10.1016/j.jacc.2015.10.093.
Rowida Almomani 1,  Judith M A Verhagen 2,  Johanna C Herkert 1,  Erwin Brosens 2,  Karin Y van Spaendonck-Zwarts 3,  Angeliki Asimaki 4,  Paul A van der Zwaag 1,  Ingrid M E Frohn-Mulder 5,  Aida M Bertoli-Avella 6,  Ludolf G Boven 1,  Marjon A van Slegtenhorst 2,  Jasper J van der Smagt 7,  Wilfred F J van IJcken 8,  Bert Timmer 9,  Margriet van Stuijvenberg 10,  Rob M Verdijk 11,  Jeffrey E Saffitz 4,  Frederik A du Plessis 5,  Michelle Michels 12,  Robert M W Hofstra 2,  Richard J Sinke 1,  J Peter van Tintelen 13,  Marja W Wessels 2,  Jan D H Jongbloed 14,  Ingrid M B H van de Laar 2
Affiliations

Affiliations

  • 1 University of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, the Netherlands.
  • 2 Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • 3 University of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, the Netherlands; Department of Clinical Genetics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
  • 4 Department of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • 5 Department of Pediatric Cardiology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • 6 Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands; Centogene AG, Rostock, Germany.
  • 7 Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands.
  • 8 Center for Biomics, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • 9 University of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, the Netherlands.
  • 10 University of Groningen, University Medical Center Groningen, Division of Neonatology, Beatrix Children's Hospital, Groningen, the Netherlands.
  • 11 Department of Pathology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • 12 Department of Cardiology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • 13 University of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, the Netherlands; Department of Clinical Genetics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; Durrer Center for Cardiogenetic Research, Utrecht, the Netherlands.
  • 14 University of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, the Netherlands. Electronic address: [email protected].
PMID: 26846950 DOI: 10.1016/j.jacc.2015.10.093
Abstract

Background: Cardiomyopathies are usually inherited and predominantly affect adults, but they can also present in childhood. Although our understanding of the molecular basis of pediatric cardiomyopathy has improved, the underlying mechanism remains elusive in a substantial proportion of cases.

Objectives: This study aimed to identify new genes involved in pediatric cardiomyopathy.

Methods: The authors performed homozygosity mapping and whole-exome sequencing in 2 consanguineous families with idiopathic pediatric cardiomyopathy. Sixty unrelated patients with pediatric cardiomyopathy were subsequently screened for mutations in a candidate gene. First-degree relatives were submitted to cardiac screening and cascade genetic testing. Myocardial samples from 2 patients were processed for histological and immunohistochemical studies.

Results: We identified 5 patients from 3 unrelated families with pediatric cardiomyopathy caused by homozygous truncating mutations in ALPK3, a gene encoding a nuclear kinase that plays an essential role in early differentiation of cardiomyocytes. All patients with biallelic mutations presented with severe hypertrophic and/or dilated cardiomyopathy in utero, at birth, or in early childhood. Three patients died from heart failure within the first week of life. Moreover, 2 of 10 (20%) heterozygous family members showed hypertrophic cardiomyopathy with an atypical distribution of hypertrophy. Deficiency of alpha-kinase 3 has previously been associated with features of both hypertrophic and dilated cardiomyopathy in mice. Consistent with studies in knockout mice, we provide microscopic evidence for intercalated disc remodeling.

Conclusions: Biallelic truncating mutations in the newly identified gene ALPK3 give rise to severe, early-onset cardiomyopathy in humans. Our findings highlight the importance of transcription factor pathways in the molecular mechanisms underlying human cardiomyopathies.

Keywords

exome sequencing; homozygous alpha-kinase 3 mutations; hypertrophy; intercalated disc.

Figures